Status:
UNKNOWN
Improving Diabetes Equity and Advancing Care Study
Lead Sponsor:
Sinai Health System
Conditions:
Diabetes
Diabetes Mellitus
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The goal of this randomized trial is to determine the optimal combination and sequence of three enhancements for a team-based care model for patients living with diabetes in Chicago. The study aim is ...
Detailed Description
Sinai Health System is Illinois' largest private safety-net healthcare system, serving predominantly low-income communities of color with large Medicaid-eligible populations in Chicago. In response to...
Eligibility Criteria
Inclusion
- A diagnosis of type 1 or type 2 diabetes
- 18+ years of age
- Able to provide consent
- Identify as African American/Black or Latinx
- most recent HbA1c \> 7%,
- Have a smartphone compatible with the Glooko application
- Have completed at least one Center appointment (i.e. current patient)
- Completed at least 3 months of their assigned study condition
Exclusion
- Already an active user of RGM
- Actively working with a CHW
- Diagnosis of gestational diabetes (without type 1 or type 2)
- Has a Power of Attorney
- Be suffering from Stage-V renal disease or undergoing dialysis.
- Be suffering from a severe form of cardiovascular disease (NYHA Class III and IV)
Key Trial Info
Start Date :
October 23 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 31 2025
Estimated Enrollment :
270 Patients enrolled
Trial Details
Trial ID
NCT06040463
Start Date
October 23 2023
End Date
March 31 2025
Last Update
December 7 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mount Sinai Hospital
Chicago, Illinois, United States, 60608